Background/Objectives:BRCA mutation carriers and women at high risk of breast/ovarian cancer are faced with the intricate question to opt for prophylactic surgeries and/or a periodic screening. The aim of this study was therefore to identify objective and emotional factors that have an impact on the decision-making process. Methods: Ninety-five women with BRCA mutations or women at increased breast/ovarian cancer lifetime risk were counseled at our outpatient department and either opted for prophylactic surgery or periodic screening. To identify the psychological factors that could have influenced the decision-making, a standardized questionnaire was applied. Additionally, clinical data were collected and were reviewed by a personal talk. Results: Seventy-one of the patients opted for an increased surveillance only, 21 for prophylactic surgeries. Positive predictors for prophylactic surgeries were sociodemographic characteristics such as parity and objective variables such as verified mutation status. Hierarchical regression analysis revealed that the need for safety in health issues has been the only significant psychological predictor of surgery beyond the objective factors. Fear of surgical procedures, menopausal symptoms after surgery, loss of attractiveness, or fear of interferences with sexual life did not significantly affect decision-making. Conclusion: Decision-making towards prophylactic surgeries is influenced by objective but also emotional factors. Knowing that fear and anxiety also have an important impact on decision-making, distinct counselling about the procedures, the subsequent risk reduction as well as the psychological effects of prophylactic surgeries are essential.

1.
Lalloo
F
,
Evans
DG
.
Familial breast cancer
.
Clin Genet
.
2012
Aug
;
82
(
2
):
105
14
.
[PubMed]
0009-9163
2.
Meindl
A
,
Ditsch
N
,
Kast
K
,
Rhiem
K
,
Schmutzler
RK
.
Hereditary breast and ovarian cancer: new genes, new treatments, new concepts
.
Dtsch Arztebl Int
.
2011
May
;
108
(
19
):
323
30
.
[PubMed]
1866-0452
3.
Kauff
ND
,
Domchek
SM
,
Friebel
TM
,
Robson
ME
,
Lee
J
,
Garber
JE
, et al.
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study
.
J Clin Oncol
.
2008
Mar
;
26
(
8
):
1331
7
.
[PubMed]
0732-183X
4.
Rebbeck
TR
,
Kauff
ND
,
Domchek
SM
.
Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers
.
J Natl Cancer Inst
.
2009
Jan
;
101
(
2
):
80
7
.
[PubMed]
0027-8874
5.
Kuchenbaecker
KB
,
Hopper
JL
,
Barnes
DR
,
Phillips
KA
,
Mooij
TM
,
Roos-Blom
MJ
, et al.;
BRCA1 and BRCA2 Cohort Consortium
.
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
.
JAMA
.
2017
Jun
;
317
(
23
):
2402
16
.
[PubMed]
0098-7484
6.
Li
X
,
You
R
,
Wang
X
,
Liu
C
,
Xu
Z
,
Zhou
J
, et al.
Effectiveness of Prophylactic Surgeries in BRCA1 or BRCA2 Mutation Carriers: A Meta-analysis and Systematic Review
.
Clin Cancer Res
.
2016
Aug
;
22
(
15
):
3971
81
.
[PubMed]
1078-0432
7.
Domchek
SM
,
Friebel
TM
,
Neuhausen
SL
,
Wagner
T
,
Evans
G
,
Isaacs
C
, et al.
Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study
.
Lancet Oncol
.
2006
Mar
;
7
(
3
):
223
9
.
[PubMed]
1470-2045
8.
Domchek
SM
,
Friebel
TM
,
Singer
CF
,
Evans
DG
,
Lynch
HT
,
Isaacs
C
, et al.
Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality
.
JAMA
.
2010
Sep
;
304
(
9
):
967
75
.
[PubMed]
0098-7484
9.
Eleje
GU
,
Eke
AC
,
Ezebialu
IU
,
Ikechebelu
JI
,
Ugwu
EO
,
Okonkwo
OO
.
Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations
.
Cochrane Database Syst Rev
.
2018
Aug
;
8
:
CD012464
.
[PubMed]
1469-493X
10.
Singh
,
K.
, et al.
,
Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers.
Am J Obstet Gynecol,
2013
. 208(4): p. 329 e1-6.
11.
Saadatmand
S
,
Obdeijn
IM
,
Rutgers
EJ
,
Oosterwijk
JC
,
Tollenaar
RA
,
Woldringh
GH
, et al.
Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC)
.
Int J Cancer
.
2015
Oct
;
137
(
7
):
1729
38
.
[PubMed]
0020-7136
12.
Metcalfe
KA
,
Birenbaum-Carmeli
D
,
Lubinski
J
,
Gronwald
J
,
Lynch
H
,
Moller
P
, et al.;
Hereditary Breast Cancer Clinical Study Group
.
International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers
.
Int J Cancer
.
2008
May
;
122
(
9
):
2017
22
.
[PubMed]
0020-7136
13.
Schott
S
,
Vetter
L
,
Keller
M
,
Bruckner
T
,
Golatta
M
,
Eismann
S
, et al.
Women at familial risk of breast cancer electing for prophylactic mastectomy: frequencies, procedures, and decision-making characteristics
.
Arch Gynecol Obstet
.
2017
Jun
;
295
(
6
):
1451
8
.
[PubMed]
0932-0067
14.
Gavaruzzi
T
,
Tasso
A
,
Franiuk
M
,
Varesco
L
,
Lotto
L
.
A Psychological Perspective on Factors Predicting Prophylactic Salpingo-Oophorectomy in a Sample of Italian Women from the General Population. Results from a Hypothetical Study in the Context of BRCA Mutations
.
J Genet Couns
.
2017
Oct
;
26
(
5
):
1144
52
.
[PubMed]
1059-7700
15.
Frost
MH
,
Slezak
JM
,
Tran
NV
,
Williams
CI
,
Johnson
JL
,
Woods
JE
, et al.
Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance
.
J Clin Oncol
.
2005
Nov
;
23
(
31
):
7849
56
.
[PubMed]
0732-183X
16.
Glassey
R
,
O’Connor
M
,
Ives
A
,
Saunders
C
,
Hardcastle
SJ
;
kConFab Investigators
.
Influences on decision-making for young women undergoing bilateral prophylactic mastectomy
.
Patient Educ Couns
.
2018
Feb
;
101
(
2
):
318
23
.
[PubMed]
0738-3991
17.
Stuckey
AR
,
Onstad
MA
.
Hereditary breast cancer: an update on risk assessment and genetic testing in 2015
.
Am J Obstet Gynecol
.
2015
Aug
;
213
(
2
):
161
5
.
[PubMed]
0002-9378
18.
Goel
NS
.
Angelina’s choice
.
South Asian J Cancer
.
2013
Oct
;
2
(
4
):
285
7
.
[PubMed]
2278-330X
19.
Borzekowski
DL
,
Guan
Y
,
Smith
KC
,
Erby
LH
,
Roter
DL
.
The Angelina effect: immediate reach, grasp, and impact of going public
.
Genet Med
.
2014
Jul
;
16
(
7
):
516
21
.
[PubMed]
1098-3600
20.
Madalinska
JB
,
van Beurden
M
,
Bleiker
EM
,
Valdimarsdottir
HB
,
Lubsen-Brandsma
L
,
Massuger
LF
, et al.
Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers
.
J Clin Oncol
.
2007
Jan
;
25
(
3
):
301
7
.
[PubMed]
0732-183X
21.
Meiser
B
,
Butow
P
,
Barratt
A
,
Friedlander
M
,
Gattas
M
,
Kirk
J
, et al.
Attitudes toward prophylactic oophorectomy and screening utilization in women at increased risk of developing hereditary breast/ovarian cancer
.
Gynecol Oncol
.
1999
Oct
;
75
(
1
):
122
9
.
[PubMed]
0090-8258
22.
van Dijk
S
,
Otten
W
,
Zoeteweij
MW
,
Timmermans
DR
,
van Asperen
CJ
,
Breuning
MH
, et al.
Genetic counselling and the intention to undergo prophylactic mastectomy: effects of a breast cancer risk assessment
.
Br J Cancer
.
2003
Jun
;
88
(
11
):
1675
81
.
[PubMed]
0007-0920
23.
Lloyd
SM
,
Watson
M
,
Oaker
G
,
Sacks
N
,
Querci della Rovere
U
,
Gui
G
.
Understanding the experience of prophylactic bilateral mastectomy: a qualitative study of ten women
.
Psychooncology
.
2000
Nov-Dec
;
9
(
6
):
473
85
.
[PubMed]
1057-9249
24.
van Driel
CM
,
Oosterwijk
JC
,
Meijers-Heijboer
EJ
,
van Asperen
CJ
,
Zeijlmans van Emmichoven
IA
,
de Vries
J
, et al.
Psychological factors associated with the intention to choose for risk-reducing mastectomy in family cancer clinic attendees
.
Breast
.
2016
Dec
;
30
:
66
72
.
[PubMed]
0960-9776
25.
Fang
CY
,
Miller
SM
,
Malick
J
,
Babb
J
,
Hurley
KE
,
Engstrom
PF
, et al.
Psychosocial correlates of intention to undergo prophylactic oophorectomy among women with a family history of ovarian cancer
.
Prev Med
.
2003
Nov
;
37
(
5
):
424
31
.
[PubMed]
0091-7435
26.
Lodder
LN
,
Frets
PG
,
Trijsburg
RW
,
Meijers-Heijboer
EJ
,
Klijn
JG
,
Seynaeve
C
, et al.
One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery)
.
Breast Cancer Res Treat
.
2002
May
;
73
(
2
):
97
112
.
[PubMed]
0167-6806
27.
Hatcher
MB
,
Fallowfield
L
,
A’Hern
R
.
The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews
.
BMJ
.
2001
Jan
;
322
(
7278
):
76
.
[PubMed]
0959-8138
28.
Hopwood
P
,
Lee
A
,
Shenton
A
,
Baildam
A
,
Brain
A
,
Lalloo
F
, et al.
Clinical follow-up after bilateral risk reducing (‘prophylactic’) mastectomy: mental health and body image outcomes
.
Psychooncology
.
2000
Nov-Dec
;
9
(
6
):
462
72
.
[PubMed]
1057-9249
29.
Croghan
IT
,
Pruthi
S
,
Hays
JT
,
Cha
S
,
Johnson
RE
,
Kosel
M
, et al.
The role of smoking in breast cancer development: an analysis of a Mayo Clinic cohort
.
Breast J
.
2009
Sep-Oct
;
15
(
5
):
489
95
.
[PubMed]
1075-122X
30.
Friebel
TM
,
Domchek
SM
,
Rebbeck
TR
.
Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis
.
J Natl Cancer Inst
.
2014
Jun
;
106
(
6
):
dju091
.
[PubMed]
0027-8874
31.
Park
J
,
Morley
TS
,
Kim
M
,
Clegg
DJ
,
Scherer
PE
.
Obesity and cancer—mechanisms underlying tumour progression and recurrence
.
Nat Rev Endocrinol
.
2014
Aug
;
10
(
8
):
455
65
.
[PubMed]
1759-5029
32.
Rose
DP
,
Gracheck
PJ
,
Vona-Davis
L
.
The Interactions of Obesity, Inflammation and Insulin Resistance in Breast Cancer
.
Cancers (Basel)
.
2015
Oct
;
7
(
4
):
2147
68
.
[PubMed]
2072-6694
33.
Lahart
IM
,
Metsios
GS
,
Nevill
AM
,
Carmichael
AR
.
Physical activity, risk of death and recurrence in breast cancer survivors: A systematic review and meta-analysis of epidemiological studies
.
Acta Oncol
.
2015
May
;
54
(
5
):
635
54
.
[PubMed]
0284-186X
34.
Bissonauth
V
,
Shatenstein
B
,
Fafard
E
,
Maugard
C
,
Robidoux
A
,
Narod
S
, et al.
Weight History, Smoking, Physical Activity and Breast Cancer Risk among French-Canadian Women Non-Carriers of More Frequent BRCA1/2 Mutations
.
J Cancer Epidemiol
.
2009
;
2009
:
748367
.
[PubMed]
1687-8558
35.
Guinan
EM
,
Hussey
J
,
McGarrigle
SA
,
Healy
LA
,
O’Sullivan
JN
,
Bennett
K
, et al.
A prospective investigation of predictive and modifiable risk factors for breast cancer in unaffected BRCA1 and BRCA2 gene carriers
.
BMC Cancer
.
2013
Mar
;
13
(
1
):
138
.
[PubMed]
1471-2407
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.